Biodistribution and toxicity of intravenously administered silica nanoparticles in mice

Archives of Toxicology

Volumn 84, Issue 3, 2010, Pages 183-190

  Xie, Guangping ^a   Sun, Jiao ^a   ZhonG , Gaoren ^b   Shi, Liyi ^c   ZhanG , Dawei ^c  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c SHANGHAI UNIVERSITY   (China)

Author keywords

Endocytosis; Nanotoxicity; Quantitative; Silica nanoparticles; Tissue distribution

Indexed keywords

NANOPARTICLE; SILICA NANOPARTICLE; SILICON DIOXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; LIVER; LIVER NECROSIS; LUNG; MACROPHAGE; MALE; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN; TISSUE DISTRIBUTION; TOXICOKINETICS; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; INJECTIONS, INTRAVENOUS; LIVER; LUNG; MALE; MICE; MICE, INBRED ICR; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; NECROSIS; PARTICLE SIZE; PHAGOSOMES; SILICON DIOXIDE; SPLEEN; TISSUE DISTRIBUTION;

MUS;

EID: 77952553605     PISSN: 03405761     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00204-009-0488-x     Document Type: Article

References (35)

1. Aderem A (2003) Phagocytosis and the inflammatory response. J Infect Dis 187:S340-S345
2. Bagwe RP, Hilliard LR, Tan W (2006) Surface modification of silica nanoparticles to reduce aggregation and nonspecific binding. Langmuir 22:4357-4362
3. Bao G, Bao XR (2005) Shedding light on the dynamics of endocytosis and viral budding. Proc Natl Acad Sci USA 102:9997-9998
4. Chithrani BD, Chan WC (2007) Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. Nano Lett 7:1542-1550
5. Chithrani BD, Ghazani AA, Chan WC (2006) Determining the size and shape dependence of gold nanoparticle uptake into mammalian cells. Nano Lett 6:662-668
6. Choi J, Burns AA, Williams RM, Zhou Z, Flesken-Nikitin A, Zipfel WR, Wiesner U, Nikitin AY (2007) Core-shell silica nanoparticles as fluorescent labels for nanomedicine. J Biomed Opt 12:064007
7. Fabian E, Landsiedel R, Ma-Hock L, Wiench K, Wohlleben W, van Ravenzwaay B (2008) Tissue distribution and toxicity of intravenously administered titanium dioxide nanoparticles in rats. Arch Toxicol 82:151-157
8. Fischer HC, Chan WC (2007) Nanotoxicity: the growing need for in vivo study. Curr Opin Biotechnol 18:565-571
9. Gao H, Shi W, Freund LB (2005) Mechanics of receptor-mediated endocytosis. Proc Natl Acad Sci USA 102:9469-9474
10. He X, Nie H, Wang K, Tan W, Wu X, Zhang P (2008) In Vivo Study of biodistribution and urinary excretion of surface-modified silica nanoparticles. Anal Chem 10:364-371
11. Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE, Hazle JD, Halas NJ, West JL (2003) Nanoshell-mediated nearinfrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA 100:13549-13554
12. Huo Q, Liu J, Wang LQ, Jiang Y, Lambert TN, Fang E (2006) A new class of silica cross-linked micellar core-shell nanoparticles. J Am Chem Soc 128:6447-6453
13. Iezzi EB, Duchamp JC, Harich K, Glass TE, Lee HM, Olmstead MM, Balch AL, Dorn HC (2002) A symmetric derivative of the trimetallic nitride endohedral metallofullerene, Sc3N@C80. J Am Chem Soc 124:524-525
14. Jain TK, Reddy MK, Morales MA, Leslie-Pelecky DL, Labhasetwar V (2008) Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol Pharm 5:316-327
15. Kim J, Lee JE, Lee J, Yu JH, Kim BC, An K, Hwang Y, Shin CH, Park JG, Hyeon T (2006) Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc 128:688-689
16. Li SD, Huang L (2008) Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm 5:496-504
17. Li ZZ, Wen LX, Shao L, Chen JF (2004) Fabrication of porous hollow silica nanoparticles and their applications in drug release control. J Control Release 98:245-254
18. Lipski AM, Pino CJ, Haselton FR, Chen IW, Shastri VP (2008) The effect of silica nanoparticle-modified surfaces on cell morphology, cytoskeletal organization and function. Biomaterials 29:3836-3846
19. Mader H, Li X, Saleh S, Link M, Kele P, Wolfbeis OS (2008) Fluorescent silica nanoparticles. Ann NY Acad Sci 1130:218-223
20. Maynard AD, Aitken RJ, Butz T, Colvin V, Donaldson K, Oberdorster G, Philbert MA, Ryan J, Seaton A, Stone V, Tinkle SS, Tran L, Walker NJ, Warheit DB (2006) Safe handling of nanotechnology. Nature 444:267-269
21. Nakai T, Kanamori T, Sando S, Aoyama Y (2003) Remarkably sizeregulated cell invasion by artificial viruses. Saccharide-dependent self-aggregation of glycoviruses and its consequences in glycoviral gene delivery. J Am Chem Soc 125:8465-8475
22. Oberdorster G, Oberdorster E, Oberdorster J (2005) Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839
23. Opanasopit P, Nishikawa M, Hashida M (2002) Factors affecting drug and gene delivery: effects of interaction with blood components. Crit Rev Ther Drug Carrier Syst 19:191-233
24. Pham KN, Fullston D, Sagoe-Crentsil K (2007) Surface modification for stability of nano-sized silica colloids. J Colloid Interface Sci 315:123-127 (Pubitemid 47410042)
25. Roy I, Ohulchanskyy TY, Bharali DJ, Pudavar HE, Mistretta RA, Kaur N, Prasad PN (2005) Optical tracking of organically modified silica nanoparticles as DNA carriers: a nonviral, nanomedicine approach for gene delivery. Proc Natl Acad Sci USA 102:279-284
26. Saba TM (1970) Physiology and physiopathology of the reticuloendothelial system. Arch Intern Med 126:1031-1052
27. Slowing II, Trewyn BG, Lin VS (2007) Mesoporous silica nanoparticles for intracellular delivery of membrane-impermeable proteins. J Am Chem Soc 129:8845-8849
28. Sonavane G, Tomoda K, Makino K (2008) Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. Colloids Surf B Biointerfaces 66:274-280
29. Stern ST, McNeil SE (2008) Nanotechnology safety concerns revisited. Toxicol Sci 101:4-21
30. Torchilin VP, Lukyanov AN, Gao Z, Papahadjopoulos-Sternberg B (2003) Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs. Proc Natl Acad Sci USA 100:6039-6044
31. Tsuji JS, Maynard AD, Howard PC, James JT, Lam CW, Warheit DB, Santamaria AB (2006) Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol Sci 89:42-50
32. Wang JJ, Sanderson BJ, Wang H (2007) Cyto- and genotoxicity of ultrafine TiO2 particles in cultured human lymphoblastoid cells. Mutat Res 628:99-106
33. Yang J, Lee J, Kang J, Lee K, Suh JS, Yoon HG, Huh YM, Haam S (2008) Hollow silica nanocontainers as drug delivery vehicles. Langmuir 24:3417-3421
34. Zhang JS, Liu F, Huang L (2005) Implications of pharmacokinetic behavior of lipoplex for its inflammatory toxicity. Adv Drug Deliv Rev 57:689-698
35. Zhao X, Hilliard LR, Mechery SJ, Wang Y, Bagwe RP, Jin S, Tan W (2004) A rapid bioassay for single bacterial cell quantitation using bioconjugated nanoparticles. Proc Natl Acad Sci USA 101:15027-15032